Garry Nolan Ph.D., Director at Akoya Biosciences, Inc. (AKYA), sold 25,000 shares at $12.67 ($317K) on 2021-12-09, disclosed to the SEC on 2021-12-13.
Open-market sale of $317k AKYA by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |
| AKYA | SELL | 2022-12-06 | $15K | — | Filing → |
| AKYA | SELL | 2022-12-02 | $67K | — | Filing → |
| AKYA | SELL | 2022-11-17 | $4K | — | Filing → |